Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

10.88
Delayed Data
As of 3:59pm ET
 -0.29 / -2.60%
Today’s Change
2.02
Today|||52-Week Range
14.48
+196.46%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close11.17
Today’s open11.29
Day’s range10.70 - 11.48
Volume2,498,228
Average volume (3 months)2,587,679
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+64.17%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp+0.35+0.85%
--Quidel Corp+0.01+0.03%
MYGNMyriad Genetics Inc-1.40-3.91%
----
Data as of 4:00pm ET, 10/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Vice President
Michael R. Garone
Director, Chief Scientific &
Patent Officer
David M. Goldenberg
Corporate headquarters
Morris Plains, New Jersey

Forecasts